Role of Brainstem Evoked Response Audiometry in Evaluating Sensorineural Hearing Loss in Diabetic Patients
Main Article Content
Abstract
Introduction
Diabetes has become a global epidemic. Hearing loss has been long associated with diabetes. Brainstem Evoked Response Audiometry (BERA) is an objective, non-invasive, electro diagnostic test that not only evaluates the functional integrity of the subcortical auditory pathway but also provides topo-diagnosis of hearing loss. This study aims to identify the role BERA in detecting hearing loss early in diabetic patients.
Materials and Methods
In this study a total of 210 patients were taken and subjected to blood glucose levels followed by PTA were divided into two groups. Group I (n=105) consisted of diabetic patients with sensorineural hearing loss (SNHL) and Group II (n=105) had age and sex matched non-diabetics with SNHL. All the patients were evaluated with BERA.
Results
All the patients were subjected to Brain Stem Evoked Response Audiometry (BERA). Absolute latency of Wave I, III, V, I-III, III-V and I-V were assessed for both the ears. In both ear Absolute latency were significantly higher in diabetics as compared to non-diabetic patients
Conclusion
The findings of present study showed that the severity of hearing loss was significantly higher in diabetic patients as compared to non-diabetic controls. Level of glycemic control showed a possible link with severity of hearing loss.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Kamba A, Daimon M, Murakami H, Otaka H, Matsuki K, Sato E, et al. Association between Higher Serum Cortisol Levels and Decreased Insulin Secretion in a General Population. PLoS One 2016; 11(11):e0166077
Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005; 26(2): 19-39
Toldo S, Boccellino M, Rinaldi B, Seropian M, Mezzaroma E, Severino A, et al. Altered oxido-reductive state in the diabetic heart: Loss of cardioprotection due to protein disulfide isomerase. Molecular Medicine 2011;17(9-10):1012-21
Joshi SR, Parikh RM. India - diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India. 2007; 55:323-4
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes-estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(3): 1047-53
Mohan V, Deepa R. Obesity and abdominal obesity in Asian Indians. Indian J Med Res. 2006; 123(5):593-6
Kansagara D, Wolf F, Freeman M, Helfand M. Management of Inpatient Hyperglycemia: A Systematic Review [Internet]. Washington (DC): Department of Veterans Affairs (US); 2008
Akinpelu OV, Mujica-Mota M, Daniel SJ. Is type 2 diabetes mellitus associated with alterations in hearing? A systematic review and meta-analysis. Laryngoscope 2014; 124(3):767-76
Mitchell P, Gopinath B, McMahon CM, Rochtchina E, Wang JJ, Boyages SC, Leeder SR. Relationship of Type 2 diabetes to the prevalence, incidence and progression of age-related hearing loss. Diabet Med. 2009; 26(5):483-8
Horikawa C, Kodama S, Tanaka S, Fujihara K, Hirasawa R, Yachi Y, et al. Diabetes and risk of hearing impairment in adults: a meta-analysis. J Clin Endocrinol Metab. 2013; 98(1):51-8
Harner SG. Hearing in adult-onset diabetes mellitus. Otolaryngol Head Neck Surg. 1981; 89(2):322-7
Dalton DS, Cruickshanks KJ, Klein R, Klein BE, Wiley TL. Association of NIDDM and hearing loss. Diabetes Care 1998; 21(9): 1540-4
de España R, Biurrun O, Lorente J, Traserra J. Hearing and diabetes. ORL J Otorhinolaryngol Relat Spec. 1995; 57(6): 325-7
Ren T, Brown NJ, Zhang M, Nuttall AL, Miller JM. A reversible ischemia model in gerbil cochlea. Hear Res.1995; 92 (1-2):30-7
Nario K, Matsunaga T, Inui H, Murai T, Miyahara H. ABR findings, electrocochleograms and caloric tests in vertebrobasilar ischemic rats. Acta Otolaryngol Suppl. 1997; 528 (Suppl) :63-6
Perlman HB, Kimura R, Fernandez C. Experiments on temporary obstruction of the internal auditory artery. Laryngoscope 1959; 69 (6):591-613
Gupta A, Mandal S. Clinical significance of brainstem evoked response audiometry in patients with diabetes mellitus. Astrocyte 2018; 4: 217-20
Sharma A, Deshpande AA, Brid SV. A Comparative Study of Brainstem Evoked Response Audiometry in Diabetic and Nondiabetic Subjects. Sch. J. App. Med. Sci. 2016; 4(8):2950-6
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32 (Suppl 1): S62–S67
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;36 (Suppl 1): S67–S74
Gupta R, Aslam M, Hasan SA, Siddiqi SS. Type -2 diabetes mellitus and auditory brainstem responses-a hospital based study. Indian J Endocrinol Metab. 2010; 14(1): 9-11
Siddiqi SS, Gupta R, Aslam M, Hasan SA, Khan SA. Type-2 diabetes mellitus and auditory brainstem response. Indian J Endocr Metab. 2013;17:1073-7
Mozaffari M, Tajik A, Ariaei N, Ali-Ehyaii F, Behnam H. Diabetes mellitus and sensorineural hearing loss among non-elderly people. East Mediterr Health J. 2010;16(9):947-52
Sharma A, Deshpande AA, Brid SV. A comparative study of brainstem evoked response audiometry in diabetic and nondiabetic subjects. Sch. J. App. Med. Sci. 2016; 4(8C):2950-6
Joshi KD, Galagali JR, Kanzhuly MK, Singh ID. A comparative study on effects of diabetes on auditory functions as measured by BERA and DPOAE. Int J Otorhinolaryngol Head Neck Surg. 2017; 3(2): 347-53
Batham C, Choudhary AK, Yousuf PS. Evaluation of auditory evoked response among type-II diabetic individuals in central India. Natl J Physiol Pharm Pharmacol. 2017;7(10):1061-9